SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LEXG-Lexicon Genetics
LXRX 1.390+3.7%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates9/25/2006 8:48:48 AM
   of 254
 
Lexicon Genetics Awarded Funding From DARPA to Identify Drug Targets With Potential for Improving Sleep-Related Performance
Monday September 25, 7:30 am ET

THE WOODLANDS, Texas, Sept. 25 /PRNewswire-FirstCall/ -- Lexicon Genetics Incorporated (Nasdaq: LEXG - News) announced today that it was awarded funding from the United States Defense Advanced Research Projects Agency (DARPA) for the identification of targets that may be important in the development of drugs to enhance the restorative benefits derived from sleep and offset problems associated with sleep deprivation. Financial terms of the one-year award were not disclosed.

Under the award, Lexicon will be investigating the molecular and cellular basis of sleep, sleep pathways and the correlation between sleep architecture and performance, including under conditions of sleep deprivation. Lexicon will also study specific genes that alter normal sleep/wake cycles when knocked out in mice. The goal of this research program is to identify potential drug targets that, when modulated, may optimize restorative sleep and improve performance after periods of sleep or under conditions of sleep deprivation.

"Through use of our proprietary drug target discovery platform, we have identified two genes that appear to impact the mechanism of sleep," said Brian P. Zambrowicz, Ph.D., executive vice president of research at Lexicon. "Our work under this grant may have application to the military and the general population."

Sleep deprivation has been demonstrated to affect physiology and behavior. Even short-term restriction of sleep can have negative consequences, including increases in blood pressure, nervous system activation, impaired glucose homeostasis and elevated inflammation. Sleep loss has also been shown to adversely affect cognitive performance. Current military operations increasingly place demands for higher levels of performance without adequate provision for opportunities to rest and sleep. Identifying novel pharmaceutical approaches aimed at preventing the harmful effects of sleep deprivation may enhance the ability of military personnel to function more safely and effectively despite prolonged periods of wakefulness.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext